As per NAVADHI Market Research, the global
pharmaceutical industry will we worth USD 1.57 trillion by 2023.
Roche is a global pioneer in pharmaceuticals and
diagnostics focused on advancing science to improve people’s lives. Roche is
one of the world’s largest biotech company, with truly differentiated medicines
in oncology, immunology, infectious diseases, ophthalmology and diseases of the
central nervous system.
Roche is also the in the forefront in vitro
diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes
management. Founded in 1896, Roche continues to search for better ways to
prevent, diagnose and treat diseases and make a sustainable contribution to
society. The company also aims to improve patient access to medical innovations
by working with all relevant stakeholders.
Thirty medicines developed by Roche are included in
the World Health Organization Model Lists of Essential Medicines, among them
life-saving antibiotics, antimalarials and cancer medicines. Roche has been
recognised as the Group Leader in sustainability within the Pharmaceuticals,
Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones
Sustainability Indices (DJSI). The Roche Group, headquartered in Basel,
Switzerland, is active in over 100 countries and in 2018 employed about 94,442
people worldwide.
Roche Holding AG reported revenue of CHF 59.497
billion for the FY 2018 which saw an increase of 6.73% compared to FY 2017.
This revenue is expected to increase by 5% and reach CHF 62.472 billion by FY
2019. Roche Holding AG registered highest revenue from United States market at
including royalties which accounted for 47.20% of its total sales in FY 2018.
In total three US national wholesale distributors
represent approximately a third of the Roche’s revenues in FY 2018. The three
US national wholesale distributors are McKesson Corp. with CHF 9 billion (2017:
CHF 7 billion), AmerisourceBergen Corp. with CHF 7 billion (2017: CHF 6
billion) and Cardinal Health, Inc. with CHF 5 billion (2017: CHF 5 billion).
Approximately 95% of these revenues were in the Pharmaceuticals operating
segment, with the residual in the Diagnostics segment.
Spanning over 31 pages and 10 exhibits, “Roche
Holding AG - Company Snapshot & SWOT Analysis” report provides value chain
analysis, financial performance, business strategy and SWOT analysis for
company.
Scope of the Roche Holding AG - Company Snapshot
& SWOT Analysis Report
- This report provides detailed information about
Roche Holding AG including value chain analysis, financial performance,
business strategy and SWOT analysis.
- The report identifies the growth drivers and
inhibitors for global pharmaceutical market.
- This report provides information about current
and future trends for global pharmaceutical market.
For more details visit: https://www.marketresearchreports.com/navadhi/roche-holding-ag-company-snapshot-swot-analysis
Browse more on Pharma andHealthcare Market Research Reports
Read our Interactive Market Research Blog
About NAVADHI Market
Research Pvt Ltd.
NAVADHI is a market research
company that helps global firms differentiate themselves, break market entry
barriers, track their investments, develop business strategies and plan for
future by providing actionable market research intelligence that helps them succeed.
Contact
us for your market research requirements: https://www.marketresearchreports.com/contact
No comments:
Post a Comment
Note: only a member of this blog may post a comment.